Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

A reliable method was developed to measure aristolochic acid-I in rat blood.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Upadacitinib improved multiple immune-related conditions in one patient.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Neurosteroids help control dopamine responses in the brain.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Low PON1 levels may indicate and predict the severity of hair loss.

5α-Reductase inhibitors don't cause depression.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.

Glutamine may protect against alopecia areata, while certain cholesterol and glucose levels may increase risk.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Dutasteride effectively treats hair loss and prostate issues.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Vitamin D receptor FokI gene variation is not linked to alopecia areata.

Biotinidase deficiency can be easily diagnosed and treated with biotin to prevent serious harm.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

5α-Reductase inhibitors can negatively impact sexual function.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Deleting the scd1 gene in mice prevents obesity by disrupting skin lipids and improving heat regulation.

Finasteride lowers cholesterol but doesn't reduce heart-related events.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.